Immune recovery in breast cancer patients after tandem high-dose chemotherapy rescued by selected CD34+ cells

被引:2
作者
Lalle, M
De Rosa, L
Pandolfi, A
Amodeo, R
De Blasio, A
Montuoro, A
Marzetti, L
机构
[1] Univ Roma La Sapienza, Clin Ginecol & Ostet 3, Rome, Italy
[2] Axienda Osped, Div Ematol, Rome, Italy
[3] Axienda Osped, Unita Trapianti Midollo Osseo, Rome, Italy
[4] Osped S Maria Goretti, Div Ematol, Latina, Italy
[5] Osped S Maria Goretti, Unita Trapianti Midollo Osseo, Latina, Italy
来源
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 2002年 / 11卷 / 06期
关键词
D O I
10.1089/152581602321080673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:991 / 994
页数:4
相关论文
共 10 条
[1]   Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors [J].
Bomberger, C ;
Singh-Jairam, M ;
Rodey, G ;
Guerriero, A ;
Yeager, AM ;
Fleming, WH ;
Holland, HK ;
Waller, EK .
BLOOD, 1998, 91 (07) :2588-2600
[2]   GENETIC MARKING SHOWS THAT PH(+) CELLS PRESENT IN AUTOLOGOUS TRANSPLANTS OF CHRONIC MYELOGENOUS LEUKEMIA (CML) CONTRIBUTE TO RELAPSE AFTER AUTOLOGOUS BONE-MARROW IN CML [J].
DEISSEROTH, AB ;
ZU, ZF ;
CLAXTON, D ;
HANANIA, EG ;
FU, SQ ;
ELLERSON, D ;
GOLDBERG, L ;
THOMAS, M ;
JANICEK, K ;
ANDERSON, WF ;
HESTER, J ;
KORBLING, M ;
DURETT, A ;
MOEN, R ;
BERENSON, R ;
HEIMFELD, S ;
HAMER, J ;
CALVERT, L ;
TIBBITS, P ;
TALPAZ, M ;
KANTARJIAN, H ;
CHAMPLIN, R ;
READING, C .
BLOOD, 1994, 83 (10) :3068-3076
[3]   Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation [J].
Friedman, J ;
Lazarus, HM ;
Koç, ON .
BONE MARROW TRANSPLANTATION, 2000, 26 (08) :831-836
[4]   Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells [J].
Hakim, FT ;
Cepeda, R ;
Kaimei, S ;
Mackall, CL ;
McAtee, N ;
Zujewski, J ;
Cowan, K ;
Gress, RE .
BLOOD, 1997, 90 (09) :3789-3798
[5]   Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation [J].
Holmberg, LA ;
Boeckh, M ;
Hooper, H ;
Leisenring, W ;
Rowley, S ;
Heimfeld, S ;
Press, O ;
Maloney, DG ;
McSweeney, P ;
Corey, L ;
Maziarz, RT ;
Appelbaum, FR ;
Bensinger, W .
BLOOD, 1999, 94 (12) :4029-4035
[6]   AGE, THYMOPOIESIS, AND CD4+ T-LYMPHOCYTE REGENERATION AFTER INTENSIVE CHEMOTHERAPY [J].
MACKALL, CL ;
FLEISHER, TA ;
BROWN, MR ;
ANDRICH, MP ;
CHEN, CC ;
FEUERSTEIN, IM ;
HOROWITZ, ME ;
MAGRATH, IT ;
SHAD, AT ;
STEINBERG, SM ;
WEXLER, LH ;
GRESS, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :143-149
[7]  
MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242
[8]   Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2 [J].
Nachbaur, D ;
Kropshofer, G ;
Feichtinger, H ;
Allerberger, F ;
Niederwieser, D .
BONE MARROW TRANSPLANTATION, 1997, 19 (12) :1261-1263
[9]  
RILL DR, 1994, BLOOD, V84, P380
[10]  
ROBERTS MM, 1993, BONE MARROW TRANSPL, V12, P469